John Maraganore

Track

Insider profile

Currently holds positions in Alnylam Pharmaceuticals Inc and Agios Pharmaceuticals, Inc.

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Executive Officer, Director Alnylam Pharmaceuticals Inc Dec. 12, 2007 -
Independent Director Agios Pharmaceuticals, Inc. Nov. 1, 2011 -
Independent Director bluebird bio Inc Jan. 1, 2012 - Sept. 18, 2018
Director Regulus Therapeutics Inc June 11, 2013 - March 28, 2014
Chairman of the Board Regulus Therapeutics Inc Jan. 2, 2009 - June 11, 2013
John Maraganore's trades of Rapport Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-22 2026-10-22
B Purchase
71,426 +16.2%
350.40
US$621,462 		71,426 +16.2% 350.40 US$621,462
2026-10-22 2026-10-22
B Purchase
37,418 +36.9%
165.34
US$3,621,126 		37,418 +36.9% 165.34 US$3,621,126
2021-11-12 2021-11-12
PlS Planned sale
57,906 +13.0%
201.26
US$1,835,621 		57,906 +13.0% 201.26 US$1,835,621
2021-11-12 2021-11-12
PlS Planned sale
683 -0.3%
173.25
US$118,330 		683 -0.3% 173.25 US$118,330
2021-11-12 2021-11-12
PlS Planned sale
14,518 -6.3%
172.22
US$2,500,290 		14,518 -6.3% 172.22 US$2,500,290
2021-11-12 2021-11-12
PlS Planned sale
7,742 -3.2%
171.35
US$1,326,592 		7,742 -3.2% 171.35 US$1,326,592
2021-11-12 2021-11-12
PlS Planned sale
10,365 -4.2%
170.36
US$1,765,781 		10,365 -4.2% 170.36 US$1,765,781
2021-05-17 2021-05-13
PlS Planned sale
1,023 -0.5%
134.37
US$137,461 		1,023 -0.5% 134.37 US$137,461
2021-05-17 2021-05-13
PlS Planned sale
1,624 -0.7%
133.56
US$216,901 		1,624 -0.7% 133.56 US$216,901
2021-05-17 2021-05-13
PlS Planned sale
3,481 -1.6%
132.32
US$460,606 		3,481 -1.6% 132.32 US$460,606
2021-05-17 2021-05-13
PlS Planned sale
11,203 -4.8%
131.18
US$1,469,610 		11,203 -4.8% 131.18 US$1,469,610
2021-05-17 2021-05-13
PlS Planned sale
9,121 -3.8%
130.34
US$1,188,831 		9,121 -3.8% 130.34 US$1,188,831
2021-05-17 2021-05-13
PlS Planned sale
4,512 -1.8%
129.32
US$583,492 		4,512 -1.8% 129.32 US$583,492
2021-05-17 2021-05-13
PlS Planned sale
3,015 -1.2%
128.30
US$386,824 		3,015 -1.2% 128.30 US$386,824
2021-02-26 2021-02-25
PlS Planned sale
599 -0.3%
154.59
US$92,599 		599 -0.3% 154.59 US$92,599
2021-02-26 2021-02-25
PlS Planned sale
431 -0.2%
153.33
US$66,085 		431 -0.2% 153.33 US$66,085
2021-02-26 2021-02-25
PlS Planned sale
1,138 -0.5%
152.46
US$173,499 		1,138 -0.5% 152.46 US$173,499
2021-02-26 2021-02-25
PlS Planned sale
1,415 -0.7%
151.31
US$214,104 		1,415 -0.7% 151.31 US$214,104
2021-02-26 2021-02-25
PlS Planned sale
2,054 -1.0%
150.22
US$308,552 		2,054 -1.0% 150.22 US$308,552
2021-02-26 2021-02-25
PlS Planned sale
1,364 -0.6%
148.96
US$203,181 		1,364 -0.6% 148.96 US$203,181
2021-02-26 2021-02-25
PlS Planned sale
4,375 -2.0%
148.00
US$647,500 		4,375 -2.0% 148.00 US$647,500
2021-02-26 2021-02-25
PlS Planned sale
6,097 -2.7%
146.98
US$896,137 		6,097 -2.7% 146.98 US$896,137
2021-02-26 2021-02-25
PlS Planned sale
9,376 -4.0%
146.13
US$1,370,115 		9,376 -4.0% 146.13 US$1,370,115
2021-02-26 2021-02-25
PlS Planned sale
6,129 -2.6%
145.15
US$889,624 		6,129 -2.6% 145.15 US$889,624
2021-02-26 2021-02-25
PlS Planned sale
1,001 -0.4%
143.88
US$144,024 		1,001 -0.4% 143.88 US$144,024
2020-11-20 2020-11-19
PlS Planned sale
102 -0.1%
126.62
US$12,915 		102 -0.1% 126.62 US$12,915
2020-11-20 2020-11-19
PlS Planned sale
10,187 -4.9%
125.35
US$1,276,940 		10,187 -4.9% 125.35 US$1,276,940
2020-11-20 2020-11-19
PlS Planned sale
5,489 -2.6%
124.49
US$683,326 		5,489 -2.6% 124.49 US$683,326
2020-11-20 2020-11-19
PlS Planned sale
18,987 -8.2%
123.55
US$2,345,844 		18,987 -8.2% 123.55 US$2,345,844
2020-08-21 2020-08-20
PlS Planned sale
8,542 -4.1%
136.86
US$1,169,058 		8,542 -4.1% 136.86 US$1,169,058
2020-08-21 2020-08-20
PlS Planned sale
21,448 -9.4%
136.07
US$2,918,429 		21,448 -9.4% 136.07 US$2,918,429
2020-08-21 2020-08-20
PlS Planned sale
4,775 -2.1%
135.09
US$645,055 		4,775 -2.1% 135.09 US$645,055
2020-05-22 2020-05-20
PlS Planned sale
5,013 -2.5%
144.33
US$723,526 		5,013 -2.5% 144.33 US$723,526
2020-05-22 2020-05-20
PlS Planned sale
16,315 -7.5%
143.46
US$2,340,550 		16,315 -7.5% 143.46 US$2,340,550
2020-05-22 2020-05-20
PlS Planned sale
13,437 -5.8%
142.51
US$1,914,907 		13,437 -5.8% 142.51 US$1,914,907
2020-02-21 2020-02-20
PlS Planned sale
502 -0.3%
133.42
US$66,977 		502 -0.3% 133.42 US$66,977
2020-02-21 2020-02-20
PlS Planned sale
18,065 -8.7%
132.81
US$2,399,213 		18,065 -8.7% 132.81 US$2,399,213
2020-02-21 2020-02-20
PlS Planned sale
6,887 -3.2%
131.61
US$906,398 		6,887 -3.2% 131.61 US$906,398
2020-02-21 2020-02-20
PlS Planned sale
5,053 -2.3%
131.07
US$662,297 		5,053 -2.3% 131.07 US$662,297
2020-02-21 2020-02-20
PlS Planned sale
1,586 -0.7%
129.33
US$205,117 		1,586 -0.7% 129.33 US$205,117
2020-02-21 2020-02-20
PlS Planned sale
2,672 -1.2%
128.62
US$343,673 		2,672 -1.2% 128.62 US$343,673
2019-10-16 2019-10-14
PlS Planned sale
1,870 -1.0%
80.31
US$150,180 		1,870 -1.0% 80.31 US$150,180
2019-10-16 2019-10-14
PlS Planned sale
26,754 -12.2%
79.80
US$2,134,969 		26,754 -12.2% 79.80 US$2,134,969
2019-10-16 2019-10-14
PlS Planned sale
20,832 -8.7%
78.92
US$1,644,061 		20,832 -8.7% 78.92 US$1,644,061
2019-05-17 2019-05-15
PlS Planned sale
49,457 -20.7%
70.00
US$3,461,990 		49,457 -20.7% 70.00 US$3,461,990